RecruitingNot ApplicableNCT07276711

CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material

Controlled Arterial Protection to Ultimately Remove Embolic Material

Sponsor

EmStop Inc

Enrollment

663 participants

Start Date

May 12, 2026

Study Type

INTERVENTIONAL

Conditions

Aortic Valve Disease Aortic Stenosis Aortic Valve Stenosis

Summary

The objective of this study is to demonstrate safety and efficacy of the EmStop Embolic Protection System when used as indicated to capture and remove thrombus/debris during self-expanding transcatheter aortic valve replacement (TAVR) procedures.

Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Boston Scientific Sentinel and a medical device called EmStop Embolic Protection System for people with aortic stenosis, aortic valve disease, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 22 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.